Three of the nation’s major drug manufacturers sued the Trump administration on Friday to block a rule that would force them to put the price of their drugs in television advertisements beginning this summer. It also claims that the ad disclosures, which require drug manufacturers to include the list price of any drug that costs more than $35 a month, could mislead consumers because insurers often cover the bulk of a drug’s cost. Lilly, which is one of three manufacturers of insulin under scrutiny for rising list prices — said the federal government had overstepped its authority. “The impetus for the lawsuit is drug prices in TV ads, but the crux of it is H.H.S. not having the authority to mandate this action,” the company said in a statement, referring to the Department of Health and Human Services.

Source: New York Times June 14, 2019 20:41 UTC